Carregant...
Targeted Activation of T Cells with IL-2-Coupled Nanoparticles
Interleukin-2 (IL-2) is a T cell growth factor particularly required in regulatory T cell maintenance and memory T cell responses. High-dose IL-2 treatment was the first FDA-approved immunotherapy for cancer, while low-dose IL-2 administration has shown promise in allograft rejection and autoimmune...
Guardat en:
| Publicat a: | Cells |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565705/ https://ncbi.nlm.nih.gov/pubmed/32917054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9092063 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|